Comparison of the effect of orlistat with and without levocarnitine on insulin resistance in obese patients with type 2 diabetes mellitus inadequately controlled with insulin or oral antihyperglycaemics.
Phase of Trial: Phase III
Latest Information Update: 01 Oct 2011
At a glance
- Drugs Levocarnitine (Primary) ; Orlistat (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 01 Oct 2011 Results published in Fundamental and Clinical Pharmacology.
- 12 Jan 2011 New trial record